Search, find and save your favorites – Use Bayer's Quick Finder to find content that is relevant to you.

黑洞加速器插件

Bayer completes biggest
acquisition in its history

怎么使用youtube
Download Full Report (PDF, 0.8MB) Bayer Newsletter Investor Conference Call

黑洞加速器插件

Group sales

9.5 billion

+ 8.5 %

网络加速|网络加速器|免费加速器|上网加速器-ZOL软件下载:2021-5-19 · 网络加速下载提供网络加速器,免费加速器,上网加速器等相关下载软件,网络加速用户热评软件排行,新鲜软件排行等向您推荐最受关注和最新的网络加速工具。更多网络加速尽在中关村在线下载频 …

EBITDA before special items

2.3 billion

+ 3.9 %

Group EBITDA before special items rose by 3.9% to €2,335 million.

Core earnings per share

怎么使用youtube

Core earnings per share from continuing operations increased by 1.3% to €1.54 (Q2 2017: €1.52).

Sales, Earnings and Financial Position

黑洞加速器插件

Pharmaceuticals

Sales of Pharmaceuticals rose by 3.1% (Fx & portfolio adj.) to €4,217 million in the second quarter of 2018. Our key growth products Xarelto™, Eylea™, Xofigo™, Stivarga™ and Adempas™ maintained their strong performance overall, with their combined sales rising by 13.2% (Fx and portfolio adj.) to €1,691 million (Q2 2017: €1,555 million).

Find out more

Consumer Health

Sales of Consumer Health declined slightly in the second quarter of 2018, falling by 1.4% (Fx & portfolio adj.) to €1,413 million. This was primarily due to a decline in business in Europe / Middle East / Africa and weaker business performance in North America.

怎么使用youtube

Crop Science

In the second quarter of 2018, Crop Science posted sales of €3,011 million. The businesses being divested accounted for €468 million of this figure. Sales increased by 39.2% on a reported basis, thanks mainly to a positive portfolio effect of 25.0% (€543 million) from the acquisition of Monsanto.

Find out more